Highlights and Quick Summary
- Cash and Short Term Investments for the quarter ending September 30, 2022 was $5.06 Million (a -7.25% decrease compared to previous quarter)
- Year-over-year quarterly Cash and Short Term Investments decreased by -24.21%
- Annual Cash and Short Term Investments for 2021 was $6.68 Million (a 27598.76% increase from previous year)
- Annual Cash and Short Term Investments for 2019 was $24.1 Thousand (a -97.48% decrease from previous year)
- Annual Cash and Short Term Investments for 2018 was $955 Thousand (a 38.4% increase from previous year)
Visit stockrow.com/BBLG
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Cash and Short Term Investments of Bone Biologics Corp.
Most recent Cash and Short Term Investmentsof BBLG including historical data for past 10 years.Interactive Chart of Cash and Short Term Investments of Bone Biologics Corp.
Bone Biologics Corp. Cash and Short Term Investments for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $5.06 | $5.45 | $5.81 | – |
| 2021 | $6.68 | $6.68 | $0.0 | $0.07 | $6.68 |
| 2020 | – | – | – | $0.0 | – |
| 2019 | – | – | – | $0.02 | $0.02 |
| 2018 | – | – | – | – | $0.96 |
| 2017 | – | – | – | – | $0.69 |
| 2016 | – | – | – | – | $0.62 |
Business Profile of Bone Biologics Corp.
Sector: Healthcare
Industry: Medical Devices